AOD-9604 Third-Party Tested COA Available AOD-9604 is a synthetic peptide fragment (176191) of human growth hormone used in laboratory research for receptor binding and metabolic signaling studies
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
Common side effects may include: Dizziness Pain, swelling, or itching at the injection site Diarrhea Nausea Skin rash or acne-like skin Unwell or feeling of weakness Serious side effects may include: Difficulty breathing Swelling of the face, lips, or tongue Irregular heartbeats or palpitations Swelling or pain in the limbs due to blood clots Severe dizziness or weakness This list does not cover all potential side effects, and others may occur
How long does it take for AOD-9604 side effects to appear
Individuals with Pernicious Anemia: This condition affects the ability to absorb B12, often requiring lifelong supplementation
Beyond obesity research, 5-Amino-1MQ has also been explored in studies involving regenerative biology, cellular senescence, fibrosis, and cancer metabolism, where NNMT expression has been associated with altered cellular metabolic states